Need recommendations for pancreatic cancer stage 4 that has spread to the liver. What treatment options are available

Pancreatic CancerNovember 14, 2026Written by Navis AI

I'm sorry you or someone you love is facing this diagnosis. Below is an educational overview of how stage 4 pancreatic cancer with liver spread is generally approached, based on NCCN guidance. Your oncologist will determine the right plan for your specific situation.

Why treatment looks different at stage 4

According to the NCCN Guidelines for Patients: Pancreatic Cancer, stage 4 (metastatic) disease has spread far from the pancreas, most commonly to the liver, lungs, or lining of the abdomen. Surgery is generally not an option for metastatic cancer because the disease is in too many places to be removed. Instead, systemic therapy (whole-body drug treatment) is the main approach. The goals, per NCCN, are to control the cancer, prolong life, and maintain quality of life.

How doctors choose a treatment (the clinical reasoning)

Oncologists generally weigh a few key factors:

  1. Performance status: your ability to do day-to-day activities, often scored on the ECOG scale (0 to 4). NCCN notes that treatment must be safe, so this strongly shapes which options are appropriate.
  2. Biomarker and genetic testing results: results from testing the tumor (and sometimes your inherited genes) can open doors to targeted therapy or immunotherapy.
  3. Overall health and symptoms: including nutrition, pain, and other medical conditions.
  4. Your personal goals and preferences.

Categories of options that exist

If performance status is 0, 1, or 2 (generally more able to tolerate intensive treatment):

  • Clinical trial participation, which NCCN lists as the preferred option
  • Systemic therapy, typically combination chemotherapy regimens. Commonly used regimens in the medical literature include FOLFIRINOX (a four-drug combination of 5-FU, leucovorin, irinotecan, and oxaliplatin) and gemcitabine plus nab-paclitaxel (Abraxane). NALIRIFOX (liposomal irinotecan, 5-FU, leucovorin, and oxaliplatin) has also been studied against gemcitabine/nab-paclitaxel, as noted by Let's Win Pancreatic Cancer.

If performance status is 3 or 4 (more limited ability to do daily activities):

  • A single chemotherapy drug or targeted therapy
  • Supportive care, including radiation for symptom relief

Biomarker-guided options

NCCN notes that biomarker tests determine whether someone may benefit from targeted therapy or immunotherapy. Examples discussed in the guidelines for later lines of treatment include:

  • KRAS-directed drugs (adagrasib/Krazati, sotorasib/Lumakras) for specific KRAS mutations
  • Selpercatinib (Retevmo) for RET alterations
  • Immunotherapy (such as nivolumab plus ipilimumab, or dostarlimab) for certain biomarker profiles like microsatellite instability-high (MSI-H) or mismatch repair deficiency, which Let's Win notes is a very specific subgroup that has benefited from immunotherapy

Let's Win Pancreatic Cancer also reports that genetic testing remains underused despite 2019 guideline recommendations that all patients be offered germline testing, so it's worth asking about directly.

What happens if the first treatment stops working

NCCN describes second-line therapy, a different treatment used if the cancer grows. Chemotherapy is usually switched to a different type (for example, from a gemcitabine-based regimen to a fluoropyrimidine-based one, or vice versa). Imaging scans continue throughout treatment to monitor cancer growth.

Supportive care is part of treatment, not an alternative to it

NCCN states that everyone with pancreatic cancer should receive supportive care (also called palliative care). It addresses pain, digestive problems, nutrition, and emotional, social, and spiritual concerns, and it improves quality of life. NCCN also emphasizes that cancer treatment should be received at an experienced, high-volume center with a multidisciplinary team.

Questions to ask your oncologist

  1. What is my performance status, and how does it affect which regimens are safe for me?
  2. Has my tumor had molecular profiling (next-generation sequencing), and have I had germline genetic testing? Do any results point to targeted therapy or immunotherapy?
  3. Which first-line regimen do you recommend for me, and why? What are the likely side effects?
  4. Are there clinical trials I might qualify for, now or later?
  5. How will we monitor whether treatment is working, and what is the plan if it isn't?
  6. Can I be referred to palliative/supportive care and a dietitian right away?
  7. Would a second opinion at a high-volume pancreatic cancer center be appropriate?

Helpful resources

Let's Win Pancreatic Cancer offers a Trial Finder and a dedicated Trial Navigator service, which can help you search for clinical trials by location, prior treatment, and tumor type.

Your oncologist will determine the most appropriate approach for your case, based on the complete clinical picture, including your test results, health history, and goals.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

More questions about Pancreatic Cancer